Export

EN
FR
Ipratropium bromide
Essential medicine status
Section:
25. Medicines acting on the respiratory tract 25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease
ATC codes: R03BB01
Indication
Chronic obstructive pulmonary disease ICD11 code: CA22
INN
Ipratropium bromide
Medicine type
Chemical agent
List type
Core
Formulations
Respiratory > Inhalation > solution: 20 µg per actuation in pressurized metered dose inhaler
EML status history
First added in 2003 (TRS 920)
Changed in 2025 (TRS 1064)
Sex
All
Age
Adolescents and adults
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Ipratropium bromide
DrugBank
Ipratropium (Ipratropium bromide)
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations of essential medicines for children, the Expert Committee recommended the following changes to the listing of ipratropium on the EML: - update the listing description of inhalation delivery systems for consistency across the Model Lists and to better reflect product characteristics.